$RHE
Regional Health Properties Inc Stock $rhe

$rhe Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000100472417000049 Filed on August 14, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$6.304M	$7.164M
YoY Change	-12.0%	60.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.990M	$4.300M
YoY Change	-30.47%	10.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.171M	$1.339M
YoY Change	-12.55%	-25.53%
% of Gross Profit
Operating Expenses	$4.486M	$6.611M
YoY Change	-32.14%	13.69%
Operating Profit	$1.818M	$553.0K
YoY Change	228.75%	-140.84%
Interest Expense	$1.006M	$1.751M
YoY Change	-42.55%	-23.17%
% of Operating Profit	55.34%	316.64%
Other Income/Expense, Net	-$1.194M	-$1.760M
YoY Change	-32.16%	-28.8%
Pretax Income	$624.0K	-$1.207M
YoY Change	-151.7%	-68.45%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$20.00K	-$4.982M
YoY Change	-100.4%	-2.18%
Net Earnings / Revenue	0.32%	-69.54%
Basic Earnings Per Share		-$0.34
Diluted Earnings Per Share	$12.12K	-$3.000M
COMMON SHARES
Basic Shares Outstanding	19.77M	19.91M shares
Diluted Shares Outstanding	19.77M	19.91M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.000M	$3.200M
YoY Change	-37.5%	-79.08%
Cash & Equivalents	$2.001M	$3.249M
Short-Term Investments
Other Short-Term Assets	$3.000M	$52.60M
YoY Change	-94.3%	85.21%
Inventory
Prepaid Expenses
Receivables	$1.496M	$3.994M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.412M	$59.86M
YoY Change	-89.29%	-0.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.23M	$79.62M
YoY Change	4.53%	-38.13%
Goodwill	$2.105M	$2.105M
YoY Change	0.0%	-50.17%
Intangibles	$23.88M	$25.23M
YoY Change	-5.36%	-33.16%
Long-Term Investments
YoY Change
Other Assets	$9.398M	$3.352M
YoY Change	180.37%	46.63%
Total Long-Term Assets	$102.8M	$95.58M
YoY Change	7.6%	-37.43%
TOTAL ASSETS
Total Short-Term Assets	$6.412M	$59.86M
Total Long-Term Assets	$102.8M	$95.58M
Total Assets	$109.3M	$155.4M
YoY Change	-29.71%	-27.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.555M	$4.340M
YoY Change	-18.09%	-68.81%
Accrued Expenses	$7.900M	$4.329M
YoY Change	82.49%	-59.09%
Deferred Revenue
YoY Change
Short-Term Debt	$4.100M	$59.20M
YoY Change	-93.07%	114.49%
Long-Term Debt Due	$4.100M	$27.00M
YoY Change	-84.81%	152.34%
Total Short-Term Liabilities	$15.62M	$68.84M
YoY Change	-77.3%	32.25%
LONG-TERM LIABILITIES
Long-Term Debt	$70.00M	$56.80M
YoY Change	23.24%	-52.15%
Other Long-Term Liabilities	$3.627M	$4.078M
YoY Change	-11.06%	38.38%
Total Long-Term Liabilities	$3.627M	$4.078M
YoY Change	-11.06%	38.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.62M	$68.84M
Total Long-Term Liabilities	$3.627M	$4.078M
Total Liabilities	$89.52M	$130.1M
YoY Change	-31.2%	-25.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$104.3M	-$95.30M
YoY Change	9.45%	39.61%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$42.70M	-$33.94M
YoY Change
Total Liabilities & Shareholders Equity	$109.3M	$155.4M
YoY Change	-29.71%	-27.07%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$20.00K	-$4.982M
YoY Change	-100.4%	-2.18%
Depreciation, Depletion And Amortization	$1.171M	$1.339M
YoY Change	-12.55%	-25.53%
Cash From Operating Activities	$1.970M	$1.620M
YoY Change	21.6%	-120.05%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	-$20.00K
YoY Change	900.0%	-94.29%
Acquisitions
YoY Change
Other Investing Activities	-$1.380M	$2.990M
YoY Change	-146.15%	-147.84%
Cash From Investing Activities	-$1.580M	$2.960M
YoY Change	-153.38%	-144.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.720M	-3.590M
YoY Change	-24.23%	-118.56%
NET CHANGE
Cash From Operating Activities	1.970M	1.620M
Cash From Investing Activities	-1.580M	2.960M
Cash From Financing Activities	-2.720M	-3.590M
Net Change In Cash	-2.330M	990.0K
YoY Change	-335.35%	-78.71%
FREE CASH FLOW
Cash From Operating Activities	$1.970M	$1.620M
Capital Expenditures	-$200.0K	-$20.00K
Free Cash Flow	$2.170M	$1.640M
YoY Change	32.32%	-121.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	adk	Accrued Payroll Related Expenses Current AccruedPayrollRelatedExpensesCurrent	442000	USD
CY2017Q2	adk	Accrued Payroll Related Expenses Current AccruedPayrollRelatedExpensesCurrent	384000	USD
CY2016Q4	adk	Allowance For Uncollectible Accounts Patient Care Receivables AllowanceForUncollectibleAccountsPatientCareReceivables	7500000	USD
CY2017Q2	adk	Allowance For Uncollectible Accounts Patient Care Receivables AllowanceForUncollectibleAccountsPatientCareReceivables	4300000	USD
	adk	Debt Instrument Financial Covenant Achieved Minimum Ebitdar DebtInstrumentFinancialCovenantAchievedMinimumEBITDAR	430000	USD
	adk	Debt Instrument Financial Covenant Required Minimum Ebitdar DebtInstrumentFinancialCovenantRequiredMinimumEBITDAR	500000	USD
	adk	Debt Instrument Financial Covenant Required Minimum Ebitdar Future Requirement DebtInstrumentFinancialCovenantRequiredMinimumEBITDARFutureRequirement	500000	USD
CY2017Q2	adk	Debt Instrument Numberof Credit Related Instruments DebtInstrumentNumberofCreditRelatedInstruments	28	credit_instrument
CY2017Q2	adk	Debt Instruments Maturities Maturingin Oneand Two Fiscal Years DebtInstrumentsMaturitiesMaturinginOneandTwoFiscalYears	10500000	USD
CY2017Q2	adk	Debt Long Term And Short Term Combined Amount Before Unamortized Discount Premium DebtLongTermAndShortTermCombinedAmountBeforeUnamortizedDiscountPremium	76451000	USD
CY2016Q4	adk	Escrow Deposit Current EscrowDepositCurrent	529000	USD
CY2017Q2	adk	Escrow Deposit Current EscrowDepositCurrent	580000	USD
CY2016Q4	adk	Long Term Bond Non Current LongTermBondNonCurrent	6586000	USD
CY2017Q2	adk	Long Term Bond Non Current LongTermBondNonCurrent	6529000	USD
CY2017Q2	adk	Longterm Debt Maturities Repaymentsof Principalin Next Twelve Months Amortization LongtermDebtMaturitiesRepaymentsofPrincipalinNextTwelveMonthsAmortization	1900000	USD
	adk	Noncashor Part Noncash Proceedsfrom Financing NoncashorPartNoncashProceedsfromFinancing	0	USD
	adk	Noncashor Part Noncash Proceedsfrom Financing NoncashorPartNoncashProceedsfromFinancing	385000	USD
	adk	Noncashor Part Noncash Proceedsfrom Vendor Financed Insurance NoncashorPartNoncashProceedsfromVendorFinancedInsurance	0	USD
	adk	Noncashor Part Noncash Proceedsfrom Vendor Financed Insurance NoncashorPartNoncashProceedsfromVendorFinancedInsurance	198000	USD
	adk	Noncashor Part Noncash Surrenderof Security Deposit NoncashorPartNoncashSurrenderofSecurityDeposit	0	USD
	adk	Noncashor Part Noncash Surrenderof Security Deposit NoncashorPartNoncashSurrenderofSecurityDeposit	500000	USD
CY2017Q2	adk	Number Of Facilities NumberOfFacilities	30	facility
	adk	Number Of Sublease Agreements Executed NumberOfSubleaseAgreementsExecuted	27	facility
CY2017Q2	adk	Numberof Independent Living Facilities NumberofIndependentLivingFacilities	1	facility
CY2017Q2	adk	Numberof Skilled Nursing Facilities Managedon Behalfof Third Party NumberofSkilledNursingFacilitiesManagedonBehalfofThirdParty	2	facility
CY2017Q2	adk	Numberof Sublease Agreements Executed Leasedby Company NumberofSubleaseAgreementsExecutedLeasedbyCompany	11	facility
CY2017Q2	adk	Numberof Sublease Agreements Executed Ownedby Company NumberofSubleaseAgreementsExecutedOwnedbyCompany	14	facility
CY2017Q2	adk	Operating Lease Escalation Percentage Initial Term Percentage OperatingLeaseEscalationPercentageInitialTermPercentage	0.03
	adk	Operating Lease Rent Revenue Discount Percentage OperatingLeaseRentRevenueDiscountPercentage	0.5
	adk	Operating Lease Rent Revenue Periodfor Discounted Rent OperatingLeaseRentRevenuePeriodforDiscountedRent	P5M
	adk	Operating Lease Rent Revenue Periodfor Dollar One Rent OperatingLeaseRentRevenuePeriodforDollarOneRent	P3M
	adk	Operating Lease Rent Revenue Property Under Rectification OperatingLeaseRentRevenuePropertyUnderRectification	1	USD
	adk	Operating Leases Numberof Skilled Nursing Facilities Leased OperatingLeasesNumberofSkilledNursingFacilitiesLeased	11	facility
CY2016Q4	adk	Replacement Reserves Current ReplacementReservesCurrent	811000	USD
CY2017Q2	adk	Replacement Reserves Current ReplacementReservesCurrent	765000	USD
CY2016Q4	adk	Restricted Cashand Cash Equivalent Reservefor Specified Purpose Including Escrow RestrictedCashandCashEquivalentReserveforSpecifiedPurposeIncludingEscrow	1590000	USD
CY2017Q2	adk	Restricted Cashand Cash Equivalent Reservefor Specified Purpose Including Escrow RestrictedCashandCashEquivalentReserveforSpecifiedPurposeIncludingEscrow	1841000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001004724
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19762036	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	ADCARE HEALTH SYSTEMS, INC
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3037000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3555000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2429000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1496000	USD
CY2016Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	557000	USD
CY2017Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	436000	USD
CY2016Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	9077000	USD
CY2017Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7935000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21816000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21629000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	154000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	240000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	720000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-80000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	154000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7529000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4267000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	433000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	166000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	378000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	838000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	339000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	677000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4516000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2385000	shares
CY2016Q4	us-gaap	Assets Assets	119486000	USD
CY2017Q2	us-gaap	Assets Assets	109252000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	20469000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	6412000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2720000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3249000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14045000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2001000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	529000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12044000	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-671000	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-312000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2252000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-933000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2017Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19927000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19762000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19927000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19762000	shares
CY2016Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	61643000	USD
CY2017Q2	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	61610000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9136000	USD
CY2017Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1494000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	13154000	USD
CY2017Q2	us-gaap	Debt Current DebtCurrent	4133000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	82357000	USD
CY2017Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	76451000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	191000	USD
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	184000	USD
CY2017Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	74200000	USD
CY2017Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	74177000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	226000	USD
CY2017Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	226000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	961000	USD
	us-gaap	Depreciation Depreciation	2214000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	832000	USD
	us-gaap	Depreciation Depreciation	1629000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1339000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3052000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1171000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2306000	USD
CY2016Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-3775000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-4303000	USD
CY2017Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-604000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1017000	USD
CY2016Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1801000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3578000	USD
CY2017Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1912000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3790000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.53
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7610000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8287000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32163000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32163000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2754000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2420000	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-63000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2135000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4677000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	822000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2444000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	2105000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	2105000	USD
CY2016Q4	us-gaap	Goodwill Gross GoodwillGross	2945000	USD
CY2017Q2	us-gaap	Goodwill Gross GoodwillGross	2945000	USD
CY2016Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	840000	USD
CY2017Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	840000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1207000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2629000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	624000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	86000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1207000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2629000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	624000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	85000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.15
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.31
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.19
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4303000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1017000	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.19
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.22
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.03
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.05
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-16000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	384000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	244000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-176000	USD
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-1344000	USD
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-1502000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	620000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	138000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-30000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	101000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1251000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-27000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-4774000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-1795000	USD
CY2016Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2471000	USD
CY2017Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2471000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24553000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23876000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	1751000	USD
	us-gaap	Interest Expense InterestExpense	3576000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	1006000	USD
	us-gaap	Interest Expense InterestExpense	2038000	USD
	us-gaap	Interest Paid InterestPaid	3213000	USD
	us-gaap	Interest Paid InterestPaid	1889000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	251000	USD
CY2017Q2	us-gaap	Interest Payable Current InterestPayableCurrent	248000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	95987000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	89520000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119486000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	109252000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25268000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	15623000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	79970000	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	74177000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	4139000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	54883000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	5568000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	2958000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	2560000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	6343000	USD
CY2016Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	66816000	USD
CY2017Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	70044000	USD
CY2016Q2	us-gaap	Management Fees Revenue ManagementFeesRevenue	274000	USD
	us-gaap	Management Fees Revenue ManagementFeesRevenue	507000	USD
CY2017Q2	us-gaap	Management Fees Revenue ManagementFeesRevenue	359000	USD
	us-gaap	Management Fees Revenue ManagementFeesRevenue	719000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6609000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13602000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-5938000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-13290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7101000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	7102000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-114000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1672000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2289000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2605000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-4982000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6932000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	20000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-932000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6783000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10510000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1892000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4722000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1760000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3627000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1194000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2384000	USD
CY2016Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	4018000	USD
CY2017Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2600000	USD
CY2017Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	2639000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	4125000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	6611000	USD
	us-gaap	Operating Expenses OperatingExpenses	13248000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	4486000	USD
	us-gaap	Operating Expenses OperatingExpenses	9969000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	553000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	998000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1818000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2470000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	84902000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8830000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8671000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8492000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8331000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	46456000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	239859000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	23886000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	23299000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	22764000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	22281000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear	10816000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	136813000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	4122000	USD
CY2016Q2	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	6890000	USD
	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	13739000	USD
CY2017Q2	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	5945000	USD
	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	11720000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2168000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4347000	USD
CY2017Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2170000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4341000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	903000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	767000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7244000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9398000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3677000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3627000	USD
CY2016Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	41000	USD
CY2017Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	628000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-283000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-188000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	312000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	187000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	67000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3578000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3790000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	534000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	1375000	USD
CY2016Q4	us-gaap	Pledged Assets Not Separately Reported Other Financial Instruments PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments	260000	USD
CY2017Q2	us-gaap	Pledged Assets Not Separately Reported Other Financial Instruments PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments	16000	USD
CY2016Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2017Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2016Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	69038000	USD
CY2017Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	70288000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2762000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2812000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2762000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2812000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	61446000	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	62434000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2395000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1554000	USD
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	1000000	USD
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	4547000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	989000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	203000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	4100000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1372000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Profit Loss ProfitLoss	-932000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	100984000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	104856000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79168000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83227000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	455000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	409000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	310000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1361000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	85000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	90000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1600000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	7700000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6646000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2512000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2016Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	5464000	USD
CY2017Q2	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	3669000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1600000	USD
CY2017Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1361000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	3864000	USD
CY2017Q2	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	2308000	USD
CY2016Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	2274000	USD
CY2017Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	467000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99590000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-104312000	USD
CY2016Q2	us-gaap	Revenues Revenues	7164000	USD
	us-gaap	Revenues Revenues	14246000	USD
CY2017Q2	us-gaap	Revenues Revenues	6304000	USD
	us-gaap	Revenues Revenues	12439000	USD
CY2016Q4	us-gaap	Security Deposit SecurityDeposit	1411000	USD
CY2017Q2	us-gaap	Security Deposit SecurityDeposit	911000	USD
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	6924000	USD
CY2017Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	6100000	USD
CY2016Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	60189000	USD
CY2017Q2	us-gaap	Senior Long Term Notes SeniorLongTermNotes	62887000	USD
CY2016Q2	us-gaap	Severance Costs1 SeveranceCosts1	969000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	1172000	USD
CY2017Q2	us-gaap	Severance Costs1 SeveranceCosts1	323000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	878000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	720000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	154000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0143
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0000
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	594179	shares
CY2017Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	210000	shares
CY2017Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	245000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.41
CY2017Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.48
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y0M01D
CY2017Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	4100000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	187000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-37947000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	-42702000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-37947000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-42702000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2196000	USD
CY2017Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2090000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19907000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19896000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19766000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19795000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19907000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19896000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19766000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19795000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19907000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19896000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19766000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19795000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported results of operations during the reporting period. Examples of significant estimates include allowance for doubtful accounts, self-insurance reserves, deferred tax valuation allowance, fair value of employee and nonemployee stock based awards, valuation of goodwill and other long-lived assets, and cash flow projections. Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001004724-17-000049-index-headers.html	Edgar Link	pending
0001004724-17-000049-index.html	Edgar Link	pending
0001004724-17-000049.txt	Edgar Link	pending
0001004724-17-000049-xbrl.zip	Edgar Link	pending
a06302017-documentx10q.htm	Edgar Link	pending
a06302017-ex311.htm	Edgar Link	pending
a06302017-ex321.htm	Edgar Link	pending
a106fourthamendmenttote001.jpg	Edgar Link	pending
a106fourthamendmenttote002.jpg	Edgar Link	pending
a106fourthamendmenttote003.jpg	Edgar Link	pending
a106fourthamendmenttote004.jpg	Edgar Link	pending
a106fourthamendmenttote005.jpg	Edgar Link	pending
a106fourthamendmenttote006.jpg	Edgar Link	pending
a106fourthamendmenttote007.jpg	Edgar Link	pending
a106fourthamendmenttote008.jpg	Edgar Link	pending
a106fourthamendmenttote009.jpg	Edgar Link	pending
a106fourthamendmenttote010.jpg	Edgar Link	pending
a106fourthamendmenttote011.jpg	Edgar Link	pending
a106fourthamendmenttote012.jpg	Edgar Link	pending
a106fourthamendmenttote013.jpg	Edgar Link	pending
a106fourthamendmenttote014.jpg	Edgar Link	pending
a106fourthamendmenttote015.jpg	Edgar Link	pending
a106fourthamendmenttote016.jpg	Edgar Link	pending
a106fourthamendmenttote017.jpg	Edgar Link	pending
a106fourthamendmenttote018.jpg	Edgar Link	pending
a106fourthamendmenttote019.jpg	Edgar Link	pending
a106fourthamendmenttote020.jpg	Edgar Link	pending
a106qcloanamend.htm	Edgar Link	pending
a107northwestpropertyho001.jpg	Edgar Link	pending
a107northwestpropertyho002.jpg	Edgar Link	pending
a107northwestpropertyho003.jpg	Edgar Link	pending
a107northwestpropertyho004.jpg	Edgar Link	pending
a107northwestpropertyho005.jpg	Edgar Link	pending
a107nwloanamend.htm	Edgar Link	pending
adk-20170630.xml	Edgar Link	completed
adk-20170630.xsd	Edgar Link	pending
adk-20170630_cal.xml	Edgar Link	unprocessable
adk-20170630_def.xml	Edgar Link	unprocessable
adk-20170630_lab.xml	Edgar Link	unprocessable
adk-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RHE
Regional Health Properties Inc Stock $rhe

2017 Q2 Form 10-Q Financial Statement

#000100472417000049 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RHE Regional Health Properties Inc Stock $rhe

2017 Q2 Form 10-Q Financial Statement

#000100472417000049 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RHE
Regional Health Properties Inc Stock $rhe